Team Sky has had some great days so far with Geraint Thomas giving an amazing performance at Criterium du Dauphine and climbing to third overall and on the other hand, hearing the news that their main rider, Chris Froome, won’t be in any way stopped from becoming part of this season’s Tour de France which starts on July 7.
The news the British team received indicated that there would be no attempt to block four-time Tour de France winner’s plan to become part of this year’s event as well.
Both Chris Froome and his squad can now breathe in peace after fearing that the Tour organizers might try to put into action a “disrepute” clause in their riding rules.
According to Christian Prudhomme, the Tour de France race CEO, any race suspension is a decision that can only come from the UCI.
Froome returned twice the allowed level of an asthma drug called salbutamol in his urine test during last season’s Vuelta a Espana event where he took the title.
And since then, the UCI has opened an investigation to find out the truth about his asthma-related health problems, his physical state which may have been unable to properly process the drug indicating more than the allowed amount in his system and other crucial components before making a decision.
Froome, who just won this season’s Giro d’Italia, grabbing six grand tour victories so far, has always denied any wrongdoing and has put his lawyers into action to protect his claims and let everyone know the truth.
“David Lappartient said it multiple times, it is a decision that must be taken by the UCI,” Prudhomme added.
“Cycling works like anything else. We are the organizers [but] we don’t make the rules.”
Cycling and the planet : Tour de France rides for the bicycle ➡️ https://t.co/dkBo2Te3gB
— Le Tour de France (@LeTour) June 5, 2018